Search Results - "Keet, Mary"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet?

    Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet? by Amtul, Zareen, Keet, Mary, Wang, Lin, Merrifield, Peter, Westaway, David, Rozmahel, Richard F

    Published in PloS one (2017)
    “…[This corrects the article DOI: 10.1371/journal.pone.0024094.]…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    DHA supplemented in peptamen diet offers no advantage in pathways to amyloidosis: is it time to evaluate composite lipid diet?

    DHA supplemented in peptamen diet offers no advantage in pathways to amyloidosis: is it time to evaluate composite lipid diet? by Amtul, Zareen, Keet, Mary, Wang, Lin, Merrifield, Peter, Westaway, David, Rozmahel, Richard F

    Published in PloS one (08-09-2011)
    “…Numerous reports have documented the beneficial effects of dietary docosahexaenoic acid (DHA) on beta-amyloid production and Alzheimer's disease (AD). However,…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator

    Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator by Tirkos, Sam, Newbigging, Susan, Nguyen, Van, Keet, Mary, Ackerley, Cameron, Kent, Geraldine, Rozmahel, Richard F

    Published in Respiratory research (29-03-2006)
    “…Lung disease in cystic fibrosis (CF) patients is dominated by chronic inflammation with an early and inappropriate influx of neutrophils causing airway…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Amelioration of Cystic Fibrosis Intestinal Mucous Disease in Mice by Restoration of mCLCA3

    Amelioration of Cystic Fibrosis Intestinal Mucous Disease in Mice by Restoration of mCLCA3 by Young, Fiona D, Newbigging, Susan, Choi, Caroline, Keet, Mary, Kent, Geraldine, Rozmahel, Richard F

    Published in Gastroenterology (New York, N.Y. 1943) (01-12-2007)
    “…Background & Aims: Mice deficient of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) exhibit severe intestinal lesions, particularly mucous…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    IgG VH CDR3 regions and expression of the YYGS motif in SLE and normal immune repertoires

    IgG VH CDR3 regions and expression of the YYGS motif in SLE and normal immune repertoires by Keet, Mary Anne

    Published 01-01-1996
    “…Studies on monoclonal anti-DNA antibodies demonstrated that the YYGS motif in the VHCDR3 of heavy chains confers DNA specificity and contributes to the…”
    Get full text
    Dissertation
    Save to List
    Saved in:
  6. 6
    Characterization of the Effects of Tumour Necrosis Factor and Lipopolysaccharide on Rat Pup Aortic Endothelial Cells

    Characterization of the Effects of Tumour Necrosis Factor and Lipopolysaccharide on Rat Pup Aortic Endothelial Cells by Ouellette, Yves, Keet, Mary

    Published in Pediatric research (01-04-1999)
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    DEVELOPMENTAL CHANGES IN LIPOPOLYSACCHARIDE ACTIVATION OF RAT AORTIC ENDOTHELIAL CELLS

    DEVELOPMENTAL CHANGES IN LIPOPOLYSACCHARIDE ACTIVATION OF RAT AORTIC ENDOTHELIAL CELLS by Ouellette, Yves, Lidington, Darcy, Keet, Mary

    Published in Critical care medicine (01-01-1999)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: